Dermatology
Litfulo Samples for Healthcare Providers
Explore medication sample resources and treatment access support for clinicians prescribing Litfulo® (ritlecitinib capsules).
Litfulo® (ritlecitinib) is an oral kinase inhibitor indicated for the treatment of severe alopecia areata in appropriate patients. It is administered as a once-daily oral capsule and may be prescribed to support hair regrowth in patients with significant scalp hair loss. Litfulo® is part of a newer class of targeted therapies used in immune-mediated conditions.
Built to help reduce friction around treatment access & patient care.
Request Litfulo® (ritlecitinib capsules) sample support and treatment access assistance through DocUpdate Concierge.
Request Samples Through DocUpdate
DocUpdate provides free HIPAA-compliant mobile tools that move care forward.
Frequently Asked Questions About Litfulo Samples
Healthcare providers can download the DocUpdate app and submit a request through Concierge for medication sample and treatment access support.
Litfulo is an oral kinase inhibitor used for severe alopecia areata in eligible patients.
Litfulo may be prescribed for severe alopecia areata in adults and adolescents meeting indication criteria.
DocUpdate is designed for licensed healthcare providers with an active NPI number, including physicians, nurse practitioners, and physician assistants.
No. DocUpdate does not dispense medications or provide direct medication fulfillment. The platform helps healthcare providers navigate medication sample support and treatment access resources through Concierge.
Yes. DocUpdate provides free HIPAA-compliant tools and support resources for healthcare providers.